ECU
RGEN icon

Eisler Capital (UK)’s Repligen RGEN Stock Holding History

Eisler Capital (UK)’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,781
Closed -$3.82M – 623
2024
Q1 		$3.82M Buy
20,781
+19,238
+1,247% +$3.66M 0.03% 359
2023
Q4 		$277K Buy
+1,543
New +$240K ﹤0.01% 592

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Eisler Capital (UK)'s RGEN Position: Q2 2024 in Review

Eisler Capital (UK) sold out of Repligen (RGEN) in Q2 2024, closing a stake of 20,781 shares — an estimated $3.82M sold.

Eisler Capital (UK) first reported a position in RGEN in Q4 2023 and held it in 2 quarters. The position peaked at $3.82M in Q1 2024. 454 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Eisler Capital (UK) reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Eisler Capital (UK) sold 20,781 Repligen shares in Q2 2024, an estimated $3.82M.
  • Eisler Capital (UK) first reported a position in Repligen in Q4 2023 and held it in 2 quarters.
  • Eisler Capital (UK)'s Repligen position peaked at $3.82M in Q1 2024.
  • 454 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Eisler Capital (UK)'s 13F filing for Q2 2024, filed 13 Aug 2024.